Loading clinical trials...
Loading clinical trials...
An Open-Label, First-In-Human Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics, and Excretion in Healthy Participants
Conditions
Interventions
HOPO 14-1
Locations
1
United States
SRI International Clinical Trials Unit
Plymouth, Michigan, United States
Start Date
March 15, 2023
Primary Completion Date
August 4, 2025
Completion Date
August 4, 2025
Last Updated
November 14, 2025
Lead Sponsor
SRI International
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions